ANVISA, Brazil’s Health Surveillance Agency, has approved sale of Kemin’s ZeaONE.
Photo ©iStockphoto.com/geopaul
ANVISA, Brazil’s Health Surveillance Agency, has approved for sale ZeaONE Zeaxanthin from Kemin Health LC (Des Moines,IA). The news allows Kemin to begin immediate marketing in Brazil of ZeaONE, a zeaxanthin ingredient sourced from a parented line of marigolds.
Like lutein, zeaxanthin has shown promise for health conditions like skin health and eye health in multiple scientific studies. In a recent age-related eye disease study from the U.S. National Eye Institute (AREDS2), 2 mg of zeaxanthin plus 10 mg of Kemin’s FloraGLO lutein was found to “slow the progression of age-related macular degeneration.”
ZeaONE is commercially available under the OptiSharp Natural brand from DSM (Parsippany, NJ).
Read more:
Fierce Debate over Zeaxanthin Isomers
Lutein and Zeaxanthin Benefit Young and Old Alike
Michael Crane
Associate Editor
Nutritional Outlook Magazine
michael.crane@ubm.com
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
Arla Foods to acquired whey nutrition business from Volac International
April 22nd 2024Arla Foods Ingredients has reached an agreement to acquire Volac’s Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited.